June 14, 2021
The Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ) issued its annual report on drug pricing reforms on June 11, firing back at an array of issues raised by policymakers, such as cost transparency for new medicines in price-setting and...read more